Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb®) in patients with sepsis and septic shock

doi:10.5492/wjccm.v10.i1.22

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7373)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

463

WORD

201

HTML

3848

Figures (1-3)

250

Tables (1-5)

235

Sum=4997

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

443

Download

728

Sum=1171

Publishing Process of This Article

Item

Count

Browse

385

Download

820

Sum=1205

Jan 9, 2021 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Crit Care Med. Jan 9, 2021; 10(1): 22-34
Published online Jan 9, 2021. doi: 10.5492/wjccm.v10.i1.22

Table 1 Baseline characteristics of all the patients before initiating the therapy

Baseline characteristics	Findings, mean ± SD
Age, yr	47.46 ± 15.56
Heart rate, beats/min	117 ± 22.05
MAP, mmHg	69.15 ± 9.19
GCS	9.04 ± 3.06
APACHE-II	25.46 ± 5.06
SOFA	12.90 ± 4.37
Leucocytes, µL	15311.44 ± 7140.54
Platelets, cells/mm³	139153.48 ± 89467.72
S. Creatinine, mg/dL	2.74 ± 1.72
S. Lactate, mmoL/L	4.61 ± 2.87
PaCO₂	43.37 ± 18.22
PaO₂	94.02 ± 49.09
FiO₂	48.78 ± 43.28
PaO₂/FiO₂	118.6 ± 58.01

APACHE II: Acute physiology and chronic health evaluation; FiO2: Fraction of inspiration O₂; GCS: Glasgow coma scale; MAP: Mean arterial pressure; SD: Standard deviation; SOFA: Sequential organ failure assessment; PaCO₂: Partial pressure of carbon dioxide; PaO₂: Alveolar oxygen partial pressure.

Citation: Paul R, Sathe P, Kumar RS, Prasad S, Aleem M, Sakhalvalkar P. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb^®) in patients with sepsis and septic shock. World J Crit Care Med 2021; 10(1): 22-34
URL: https://www.wjgnet.com/2220-3141/full/v10/i1/22.htm
DOI: https://dx.doi.org/10.5492/wjccm.v10.i1.22